Brokerages Set Diamondback Energy, Inc. (NASDAQ:FANG) PT at $210.70
Shares of Diamondback Energy, Inc. (NASDAQ:FANG – Get Free Report) have earned an average rating of “Moderate Buy” from the twenty-four analysts that are presently...
3M (NYSE:MMM) Given Average Recommendation of “Moderate Buy” by Analysts
3M (NYSE:MMM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the sixteen analysts that are covering the company, Marketbeat Ratings...
3M (NYSE:MMM) Given Average Recommendation of “Moderate Buy” by Analysts
3M (NYSE:MMM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the sixteen analysts that are covering the company, Marketbeat Ratings...
The RMR Group (NASDAQ:RMR) Hits New 1-Year Low – Here’s Why
The RMR Group Inc. (NASDAQ:RMR – Get Free Report)’s share price hit a new 52-week low during trading on Monday . The company traded as...
The RMR Group (NASDAQ:RMR) Hits New 1-Year Low – Here’s Why
The RMR Group Inc. (NASDAQ:RMR – Get Free Report)’s share price hit a new 52-week low during trading on Monday . The company traded as...
Cocrystal Pharma (NASDAQ: COCP) Extends Enrollment in Phase 2a Influenza StudyCocrystal Pharma, Inc., a clinical-stage biotechnology company, has announced plans to extend enrollment in the Phase 2a human challenge study for its oral influenza PB2 in
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Cocrystal Pharma’s...